COVER STORY
INDIA’ S NEXT BIOPHARMA BOOM
Biosimilars industry eyes a billion-dollar windfall
The biopharmaceutical industry is entering a significant transformation phase as numerous blockbuster biologic drugs approach their patent expiration globally. This transition opens up vast opportunities for countries with strong pharmaceutical capabilities, and India stands to benefit immensely. We explore the scale of the patent expiry wave, its implications for the global market, and how the Indian pharmaceutical industry can position itself as a dominant player in the biosimilars and biopharma space.
By BioVoice Editorial Team
14
BioVoiceNews | April 2025